These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 7430305)
1. Determination of the concentration of adriamycin and its metabolites in the serum and tissues of Ehrlich carcinoma-bearing mice by high-performance liquid chromatography. Shinozawa S; Mimaki Y; Araki Y; Oda T J Chromatogr; 1980 Aug; 196(3):463-9. PubMed ID: 7430305 [TBL] [Abstract][Full Text] [Related]
2. Determination of adriamycin (doxorubicin) and related fluorescent compounds in rat lymph and gall by high-performance liquid chromatography. Shinozawa S; Oda T J Chromatogr; 1981 Aug; 212(3):323-30. PubMed ID: 7263801 [TBL] [Abstract][Full Text] [Related]
3. Determination of adriamycin, adriamycinol and their 7-deoxyaglycones in human serum by high-performance liquid chromatography. Cummings J; Stuart JF; Calman KC J Chromatogr; 1984 Nov; 311(1):125-33. PubMed ID: 6520153 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic analysis of adriamycin (doxorubicin) and related fluorescent compounds in Ehrlich tumor-bearing mouse plasma and tissues. Shinozawa S; Fukuda T; Araki Y; Oda T Acta Med Okayama; 1982 Apr; 36(2):125-32. PubMed ID: 7136849 [TBL] [Abstract][Full Text] [Related]
5. Determination of adriamycin and its fluorescent metabolites in human plasma by HPLC. Mahdadi R; Lhermitte M; Lafitte JJ Biomed Chromatogr; 1987 Feb; 2(1):38-40. PubMed ID: 3508093 [TBL] [Abstract][Full Text] [Related]
6. Measurement of adriamycin (doxorubicin) and its metabolites in human plasma using reversed-phase high-performance liquid chromatography and fluorescence detection. Pierce RN; Jatlow PI J Chromatogr; 1979 Dec; 164(4):471-8. PubMed ID: 541422 [TBL] [Abstract][Full Text] [Related]
7. Reversed-phase liquid chromatographic determination of plasma levels of adriamycin and adriamycinol. Eksborg S; Ehrsson H; Andersson I J Chromatogr; 1979 Dec; 164(4):479-86. PubMed ID: 541423 [TBL] [Abstract][Full Text] [Related]
8. Plasma pharmacokinetics of adriamycin and adriamycinol: implications for the design of in vitro experiments and treatment protocols. Greene RF; Collins JM; Jenkins JF; Speyer JL; Myers CE Cancer Res; 1983 Jul; 43(7):3417-21. PubMed ID: 6850648 [TBL] [Abstract][Full Text] [Related]
9. Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography. Andrews PA; Brenner DE; Chou FT; Kubo H; Bachur NR Drug Metab Dispos; 1980; 8(3):152-6. PubMed ID: 6104578 [TBL] [Abstract][Full Text] [Related]
10. Quantitative determination of adriamycin in rat hepatocytes using a volatile extraction buffer, HPLC and fluorescence detection. Mahdadi R; Pommery N; Pommery J; Lhermitte M Biomed Chromatogr; 1987; 2(3):91-4. PubMed ID: 3507221 [TBL] [Abstract][Full Text] [Related]
11. [The pharmacokinetics of adriamycin and adriamycin-metabolites (author's transl)]. Ehninger G; Stocker HJ; Proksch B; Wilms K Klin Wochenschr; 1980 Sep; 58(18):927-34. PubMed ID: 7206588 [TBL] [Abstract][Full Text] [Related]
12. Determination of adriamycin in plasma and tissue biopsies. Cox SK; Wilke AV; Frazier D J Chromatogr; 1991 Mar; 564(1):322-9. PubMed ID: 1860929 [TBL] [Abstract][Full Text] [Related]
13. Tissue distribution and antitumor effect of liposome-entrapped doxorubicin (adriamycin) in Ehrlich solid tumor-bearing mouse. Shinozawa S; Araki Y; Oda T Acta Med Okayama; 1981 Dec; 35(6):395-405. PubMed ID: 6459710 [TBL] [Abstract][Full Text] [Related]
14. Simplified toxicologic monitoring of adriamycin, its major metabolites and nogalamycin by reverse-phase high pressure liquid chromatography, Part I: Analytical techniques for isolated human plasma. Quattrone AJ; Ranney DF J Anal Toxicol; 1980; 4(1):12-5. PubMed ID: 6927044 [TBL] [Abstract][Full Text] [Related]
15. Sensitive high performance liquid chromatographic assay for assessment of doxorubicin pharmacokinetics in mouse plasma and tissues. Urva SR; Shin BS; Yang VC; Balthasar JP J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Mar; 877(8-9):837-41. PubMed ID: 19246257 [TBL] [Abstract][Full Text] [Related]
16. Determination of doxorubicin hydrochloride in pharmaceutical preparations using high-pressure liquid chromatography. Barth HG; Conner AZ J Chromatogr; 1977 Jan; 131():375-81. PubMed ID: 856858 [TBL] [Abstract][Full Text] [Related]
17. Marked inter-patient variation in adriamycin biotransformation to 7-deoxyaglycones: evidence from metabolites identified in serum. Cummings J; Milstead R; Cunningham D; Kaye S Eur J Cancer Clin Oncol; 1986 Aug; 22(8):991-1001. PubMed ID: 3770056 [TBL] [Abstract][Full Text] [Related]
18. Reversed-phase ion-pair high-performance liquid chromatography of adriamycin and adriamycinol in rat serum and tissues. Gallo JM; Hung CT; Perrier DG J Pharm Biomed Anal; 1986; 4(4):483-90. PubMed ID: 16867584 [TBL] [Abstract][Full Text] [Related]
19. Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity. Sadzuka Y; Iwazaki A; Miyagishima A; Nozawa Y; Hirota S Jpn J Cancer Res; 1995 Jun; 86(6):594-9. PubMed ID: 7622424 [TBL] [Abstract][Full Text] [Related]
20. A rapid chromatographic procedure for the determination of adriamycin, daunomycin and their 13-OH metabolites adriamycinol and daunomycinol. Erb N; Erttmann R; Landbeck G Cancer Chemother Pharmacol; 1986; 17(1):53-5. PubMed ID: 3698178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]